•  
  •  
 

Document Type

Original Article

Abstract

Cardiac hypertrophy alters vascular function and promotes myocardial damage via oxidative stress and inflammation, with calcium channels and the PI3K/AKT/eNOS signalling pathway being pivotal in vascular reactivity. Nonetheless, their precise role in acetylcholine (ACh)-mediated vascular responses during hypertrophy remains little elucidated. The study aims to investigate calcium channel functions and endothelial PI3K/AKT/eNOS signalling in modulating vascular reactivity in a rat model of cardiac hypertrophy. Aortic rings from control and ISO-treated rats were mounted in organ baths. Cumulative ACh dose–response curves (DRC) were obtained at baseline and after preincubation with Nω-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase (NOS) blocker, PI3K inhibitor, AKT inhibitor, Mas receptor antagonist (Mas blocker), and amlodipine (L-type Ca²⁺ blocker). Potency (pD₂), maximal relaxation (Emax), and area under the curve (AUC) were compared. In control vessels, Mas receptor blockade, AKT inhibition, and L-NAME each reduced ACh-induced relaxation—confirming that PI3K/AKT/eNOS-dependent nitric oxide (NO) signalling drives vasodilation. Amlodipine slightly lowered relaxation parameters, suggesting that Ca²⁺ entry supports maximal NO production. After ISO treatment, these effects were reversed: Mas blockade and amlodipine enhanced relaxation, while AKT inhibition increased pD₂ and AUC without reducing Emax. L-NAME caused weaker inhibition, reflecting impaired NO signalling. PI3K inhibition had no effect in either condition, and overall AUC changes were minimal. Isoproterenol disrupts the balance between Ca²-dependent and phosphorylation-dependent activation of eNOS, reducing NO bioavailability and rewiring Mas/AKT signalling. Reducing pathological Ca²⁺ influx and dampening AKT activity reverse endothelial responsiveness; however, Mas signalling shifts from endothelial vasoprotective in physiology to maladaptive in hypertrophy. Consequently, the L-type Ca²⁺ channels, AKT, and the Mas axis appear to be reasonable targets for rebalancing endothelial sensitivity in hypertrophic conditions.

Receive Date

21/12/2025

Revise Date

16/03/2026

Accept Date

24/03/2026

Publication Date

2026

References

1.            Saleem N, Prasad A, Goswami SK. Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat. Molecular and cellular biochemistry. 2018;445(1-2):79-88.10.1007/s11010-017-3253-0

2.            Chowdhury D, Tangutur A, D. , Khatua T, N., Saxena P, Banerjee S, K ., Bhadra P, M, et al. A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats. Journal of translational medicine. 2013;11(130)

3.            Ojo AO, Ekomaye OH, Owoade WM, Onaseso OO, Adedayo LD, Oluranti OI, et al. The effect of ginger (Zingiber officinale) feed on cardiac biomarker in medium-dose isoproterenol-induced myocardial toxicity. Avicenna journal of phytomedicine. 2021;11(1): 1-10

4.            Perez-Bonilla P, LaViolette B, Bhandary B, Ullas S, Chen X, Hirenallur-Shanthappa D, et al. Isoproterenol induced cardiac hypertrophy: A comparison of three doses and two delivery methods in C57BL/6J mice. PLoS One. 2024;19(7):e0307467.10.1371/journal.pone.0307467

5.            Drera A, Rodella L, Brangi E, Riccardi M, Vizzardi E. Endothelial Dysfunction in Heart Failure: What Is Its Role? J Clin Med. 2024;13(9).10.3390/jcm13092534

6.            Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol. 2006;26(6):1215-25.10.1161/01.ATV.0000217611.81085.c5

7.            Ghigo A, Laffargue M, Li M, Hirsch E. PI3K and Calcium Signaling in Cardiovascular Disease. Circ Res. 2017;121(3):282-92.10.1161/CIRCRESAHA.117.310183

8.            Godo S, Takahashi J, Yasuda S, Shimokawa H. Endothelium in Coronary Macrovascular and Microvascular Diseases. Journal of cardiovascular pharmacology. 2021;78(Suppl 6):S19-s29.10.1097/fjc.0000000000001089

9.            Aoyagi T, Matsui T. Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Current pharmaceutical design. 2011;17(18):1818-24.10.2174/138161211796390976

10.          Gao PC, Tan XH, Xia MC, Li KF, Zhao FZ, Ying HG, et al. Hinokiflavone alleviates high-fat diet-induced erectile dysfunction via the EGFR/PI3K/Akt/eNOS signaling pathway. Sexual medicine. 2025;13(4):qfaf059.10.1093/sexmed/qfaf059

11.          Cheng Q, Zhao Y, Li J. Sodium tanshinone IIA sulfonate suppresses heat stress-induced endothelial cell apoptosis by promoting NO production through upregulating the PI3K/AKT/eNOS pathway. Mol Med Rep. 2017;16(2):1612-8.10.3892/mmr.2017.6760

12.          Lan F, Lee AS, Liang P, Sanchez-Freire V, Nguyen PK, Wang L, et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell. 2013;12(1):101-13.10.1016/j.stem.2012.10.010

13.          Mason RP, Jacob RF, Corbalan JJ, Kaliszan R, Malinski T. Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes. American journal of hypertension. 2014;27(3):482-8.10.1093/ajh/hpt202

14.          Huige L, Ulrich F, Ning X, Marin K, Thomas M, Andreas D, et al. Pharmacological targeting of endothelial nitric oxide synthase dysfunction and nitric oxide replacement therapy. Free Radical Biology and Medicine. 2025;237:455-72.https://doi.org/10.1016/j.freeradbiomed.2025.06.009

15.          Gutierrez A, Contreras C, Sanchez A, Prieto D. Role of Phosphatidylinositol 3-Kinase (PI3K), Mitogen-Activated Protein Kinase (MAPK), and Protein Kinase C (PKC) in Calcium Signaling Pathways Linked to the alpha(1)-Adrenoceptor in Resistance Arteries. Frontiers in physiology. 2019;10:55.10.3389/fphys.2019.00055

16.          McGee MA, Abdel-Rahman AA. Enhanced vascular PI3K/Akt-NOX signaling underlies the peripheral NMDAR-mediated pressor response in conscious rats. Journal of cardiovascular pharmacology. 2014;63(5):395-405.10.1097/FJC.0000000000000059

17.          Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, et al. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiological reviews. 2018;98(1):505-53.10.1152/physrev.00023.2016

18.          Mahmood NMS, Mahmud AMR, Maulood IM. Role of Melatonin in Attenuation of Vascular Angiotensin 1-7 Reactivity Via Calcium Channels and Endothelial Derived Relaxing Factors in Induced Diabetic Aortic Rats. Iraqi Journal of Science. 2024:4256-70.10.24996/ijs.2024.65.8.11

19.          Barrera NP, Marquez M, Munoz-Uribe M, Figueroa XF. Acetylcholine activates a regenerative vasodilator mechanism that is sensitive to nitric oxide production. Frontiers in physiology. 2025;16:1569167.10.3389/fphys.2025.1569167

20.          Shaito A, Aramouni K, Assaf R, Parenti A, Orekhov A, Yazbi AE, et al. Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases. Front Biosci (Landmark Ed). 2022;27(3):105.10.31083/j.fbl2703105

21.          Kopincova J, Puzserova A, Bernatova I. L-NAME in the cardiovascular system - nitric oxide synthase activator? Pharmacol Rep. 2012;64(3):511-20.10.1016/s1734-1140(12)70846-0

22.          Stepien O, Zhang Y, Zhu D, Marche P. Dual mechanism of action of amlodipine in human vascular smooth muscle cells. Journal of hypertension. 2002;20(1):95-102.10.1097/00004872-200201000-00014

23.          Mahmood NM, Mahmud AM, Maulood IM. Protective effects of melatonin on AT1, ACE2, and Mas genes expression in induced diabetic aortic rats. Iraqi Journal of Veterinary Sciences. 2024;38(2):449-59.10.33899/ijvs.2023.144712.3324

24.          Akther F, Razan MR, Shaligram S, Graham JL, Stanhope KL, Allen KN, et al. Potentiation of Acetylcholine-Induced Relaxation of Aorta in Male UC Davis Type 2 Diabetes Mellitus (UCD-T2DM) Rats: Sex-Specific Responses. Frontiers in physiology. 2021;12:616317.10.3389/fphys.2021.616317

25.          Kim J, Park J, Shin S, Kim Y, Jung J, Bu Y, et al. PI3K/AKT/eNOS Modulation and Angiotensin II Suppression by Dryopteris crassirhizoma Rhizome Extract: Computational and Experimental Evidence. ACS omega. 2026;11(1):930-43.10.1021/acsomega.5c07735

26.          Braga VA, Couto GK, Lazzarin MC, Rossoni LV, Medeiros A. Aerobic Exercise Training Prevents the Onset of Endothelial Dysfunction via Increased Nitric Oxide Bioavailability and Reduced Reactive Oxygen Species in an Experimental Model of Menopause. PLoS One. 2015;10(4):e0125388.10.1371/journal.pone.0125388

27.          Chen X, Rateri DL, Howatt DA, Balakrishnan A, Moorleghen JJ, Morris AJ, et al. Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. PLoS One. 2013;8(11):e81743.10.1371/journal.pone.0081743

28.          Forte E, Panahi M, Baxan N, Ng FS, Boyle JJ, Branca J, et al. Type 2 MI induced by a single high dose of isoproterenol in C57BL/6J mice triggers a persistent adaptive immune response against the heart. Journal of cellular and molecular medicine. 2021;25(1):229-43.10.1111/jcmm.15937

29.          Zhao Y, Qian Y, Sun Z, Shen X, Cai Y, Li L, et al. Role of PI3K in the Progression and Regression of Atherosclerosis. Frontiers in Pharmacology. 2021;Volume 12 - 2021.10.3389/fphar.2021.632378

30.          Figueroa XF, González DR, Puebla M, Acevedo JP, Rojas-Libano D, Durán WN, et al. Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels. Journal of vascular research. 2013;50(6):498-511.10.1159/000355301

31.          Liu J, Li J, Yang S, She Y, Li X, Jia Y, et al. Phillyrin Inhibits Isoproterenol-Induced Cardiac Hypertrophy Via P38 and NF-κB Pathways. Natural Product Communications. 2022;18(1).10.1177/1934578x221144581

32.          Prajapati AK, Shah G. Exploring in vivo and in vitro models for heart failure with biomarker insights: a review. The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology. 2024;76(1):141.10.1186/s43044-024-00568-1

33.          Davel AP, Brum PC, Rossoni LV. Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathway. PLoS One. 2014;9(3):e91877.10.1371/journal.pone.0091877

34.          Ravindran S, Rau CD. The multifaceted role of mitochondria in cardiac function: insights and approaches. Cell communication and signaling : CCS. 2024;22(1):525.10.1186/s12964-024-01899-x

35.          Kithas AC, Broxterman RM, Trinity JD, Gifford JR, Kwon OS, Hydren JR, et al. Nitric oxide synthase inhibition with N(G)-monomethyl-l-arginine: Determining the window of effect in the human vasculature. Nitric oxide : biology and chemistry. 2020;104-105:51-60.10.1016/j.niox.2020.09.001

36.          Niu H, Li J, Liang H, Wu G, Chen M. Exogenous Hydrogen Sulfide Activates PI3K/Akt/eNOS Pathway to Improve Replicative Senescence in Human Umbilical Vein Endothelial Cells. Cardiol Res Pract. 2023;2023:7296874.10.1155/2023/7296874

37.          Zhang Y, Wang SJ, Han ZH, Li YQ, Xue JH, Gao DF, et al. PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells. International journal of clinical and experimental pathology. 2014;7(11):8112-7

38.          Yang Y, Wang Z, Yao M, Xiong W, Wang J, Fang Y, et al. Oxytocin Protects Against Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting PI3K/AKT Pathway via a lncRNA GAS5/miR-375-3p/KLF4-Dependent Mechanism. Front Pharmacol. 2021;12:766024.10.3389/fphar.2021.766024

39.          Meco M, Giustiniano E, Nisi F, Zulli P, Agosteo E. MAPK, PI3K/Akt Pathways, and GSK-3β Activity in Severe Acute Heart Failure in Intensive Care Patients: An Updated Review. J Cardiovasc Dev Dis. 2025;12(7).10.3390/jcdd12070266

40.          Lenasi H, Kohlstedt K, Fichtlscherer B, Mülsch A, Busse R, Fleming I, et al. Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser 1177 and Thr 495. Cardiovascular research. 2003;59(4):844-53.10.1016/s0008-6363(03)00505-4

41.          Radenković M, Stojanović M, Prostran M. Calcium Channel Blockers in Restoration of Endothelial Function: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current medicinal chemistry. 2019;26(29):5579-95.10.2174/0929867325666180713144806

42.          Zhong M, Zhou H, Long C, Zhang Y, Cui W, Zhang H, et al. Natakalim Ameliorates Isoproterenol-Induced Chronic Heart Failure by Protecting against Endothelial Dysfunction. Pharmacology. 2016;98(3-4):99-110.10.1159/000445383

43.          Zhao Y, Qian Y, Sun Z, Shen X, Cai Y, Li L, et al. Role of PI3K in the Progression and Regression of Atherosclerosis. Front Pharmacol. 2021;12:632378.10.3389/fphar.2021.632378

44.          Davel AP, Kawamoto EM, Scavone C, Vassallo DV, Rossoni LV. Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation. British journal of pharmacology. 2006;148(5):629-39.10.1038/sj.bjp.0706749

45.          Montezano AC, Kuriakose J, Hood KY, Sin YY, Camargo LL, Namkung Y, et al. Ang-(1-7) and ET-1 Interplay Through Mas and ET(B) Receptor Interaction Defines a Novel Vasoprotective Mechanism. Hypertension (Dallas, Tex : 1979). 2025;82(2):267-81.10.1161/hypertensionaha.124.22693

46.          Molaei A, Molaei E, Hayes AW, Karimi G. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases. Cell cycle (Georgetown, Tex). 2023;22(13):1654-74.10.1080/15384101.2023.2228089

47.          Zhang S, Li S, Xie S, Cui L, Gao Y, Wang Y, et al. The Role of Ca(2+)/PI3K/Akt/eNOS/NO Pathway in Astragaloside IV-Induced Inhibition of Endothelial Inflammation Triggered by Angiotensin II. Mediators Inflamm. 2024;2024:3193950.10.1155/2024/3193950

48.          Roman B, Mastoor Y, Sun J, Chapoy Villanueva H, Hinojosa G, Springer D, et al. MICU3 Regulates Mitochondrial Calcium and Cardiac Hypertrophy. Circ Res. 2024;135(1):26-40.10.1161/circresaha.123.324026

49.          Hu Z, Chen J, Wei Q, Xia Y. Bidirectional actions of hydrogen peroxide on endothelial nitric-oxide synthase phosphorylation and function: co-commitment and interplay of Akt and AMPK. J Biol Chem. 2008;283(37):25256-63.10.1074/jbc.M802455200

Download

Share

COinS